Dista-Myo2 Natural history of distal and myofibrillar myopathies

  • Research type

    Research Study

  • Full title

    Dista-Myo2: Natural history of distal and myofibrillar myopathies assessed by clinical and technological outcome measures.

  • IRAS ID

    355211

  • Contact name

    Giorgio Tasca

  • Contact email

    Giorgio.tasca@newcastle.ac.uk

  • Sponsor organisation

    Newcastle University

  • Duration of Study in the UK

    2 years, 2 months, 7 days

  • Research summary

    Dista-Myo2 is an international research study aiming to improve how we assess muscle weakness and walking difficulties in people with rare muscle conditions known as Distal Myopathies (DM) and Myofibrillar Myopathies (MFM). These diseases often affect the hands, feet, and lower limbs, leading to loss of independence and reduced quality of life.
    Currently, standard clinical methods do not fully capture how these diseases progress, especially in those more severely affected. This study is exploring new ways to identify and monitor disease progression using advanced measurement techniques. These include functional assessments, dexterity tests and MyoTools, which measure strength in the arms and legs, and in-shoe sensors, which record how a person walks in real time.
    By undertaking these assessments, we aim to gain a clearer understanding of how muscle weakness and mobility change over time in people with DM and MFM. The goal is to see whether these assessments provide meaningful insights into disease progression, which could improve how we track changes and evaluate the impact of future treatments.
    Participants will be adults diagnosed with DM or MFM. In Newcastle, up to 35 participants will be recruited from the John Walton Muscular Dystrophy Research Centre (JWMDRC) database. Recruitment will start with 20 participants, with the potential to include additional participants if possible. Those who previously took part in the original Dista-Myo study will be invited to continue for an additional 12 to 24 months. New participants will attend two study visits 12 months apart. Each visit includes walking tests, muscle strength assessments, and questionnaires about daily activities and quality of life.
    Data from the study will be analysed using statistical methods to examine changes in muscle strength, mobility, and daily function over time, allowing us to understand disease progression and the usefulness of these new assessment tools.
    Findings from this research could lead to better ways of monitoring these conditions and support the development and evaluation of future therapies.

  • REC name

    East Midlands - Nottingham 1 Research Ethics Committee

  • REC reference

    25/EM/0275

  • Date of REC Opinion

    28 Nov 2025

  • REC opinion

    Favourable Opinion